General information

Announcements(0)

Greetings from the Chair

Overview

Web abstract

Best Student Presentation Award

Selected programs of presentations in English

Registration

Registration (Non-presenters under 4th year underg

Information for Participants

Information for Presenters and Chairs

Banquet

Luncheon Seminar & Career Design Seminar

General information 2

Abstract Submission (Oral/Poster Presentation) for

Abstract Submission (Oral/Poster Presentation)

Timetable

Fri. Mar 29, 2024

Sat. Mar 30, 2024

Sun. Mar 31, 2024

Program

Sessions

Search presentations

20230323085903895_en.png

app_icon.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Enter the password to view the abstracts.<br><br>The password will be emailed to those who have completed the registration.

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Profile management

Announcements

Bookmark

Download PDF for print

Development of nanoparticle-based drug delivery systems and cell therapies for the treatment of intractable diseases

In recent years, the drug discovery research has been changing dramatically, and new drug development using new modalities such as antibody-drug conjugates, nucleic acid drugs, cell-based therapeutics, and regenerative medicine has become more active, focusing on disease areas where unmet medical needs are high. On the other hand, in order to achieve efficient delivery and introduction of these new modalities into target organs and tissues, it is important to apply nanoDDS technology that enables the control of pharmacokinetics in the body by avoiding foreign substance recognition mechanisms, overcoming in vivo barriers, and accommodating tissue-specific constructs related to the disease's pathophysiology. In this context, lipid nanoparticles and polymeric micelles have been developed so far, and recently, research and development of nanoDDS technology using extracellular vesicles like exosomes has rapidly advanced. In this symposium, we will introduce the cutting edge of nanoDDS research and development, which will lead to the development of new delivery mechanisms and therapeutic strategies. We would like to discuss strategies for the treatment of intractable diseases using nanoDDS technology that contributes new drug modalities by gaining a deeper understanding of overcoming and bypassing in vivo barriers, the biological environment, and defense mechanisms.

Cutting Edge of NanoDDS Technology Supporting New Modalities in Drug Discovery: Challenges in the Treatment of Intractable Diseases

The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)

Presentation Information

[JS10-2]Development of nanoparticle-based drug delivery systems and cell therapies for the treatment of intractable diseases

Password required to view